ライフサイエンスコーパス: stoma

1 2.10; 95% CI, 1.86 to 2.36 compared with no stoma).

2 coloanal anastomosis and without a diverting stoma.

3 on, around 17% of patients remain with their stoma.

4 s a functional anastomosis without diverting stoma.

5 Sixty-two percent had a temporary diverting stoma.

6 ctal margin in hopes of avoiding a permanent stoma.

7 ncluded prolapse and infections of the graft stoma.

8 g-term quality of life and risk of permanent stoma.

9 cribe any continent catheterizable abdominal stoma.

10 ma, compared to conventional transplant with stoma.

11 pic group and 11 in the Hartmann group had a stoma.

12 rate problems than those who had never had a stoma.

13 adaptation to and acceptance of self-with-a-stoma.

14 to increase outlet resistance, and continent stomas.

15 higher incidence of AL than those without a stoma (15.97% vs 13.25%).

16 Of respondents without a stoma, 16.3% reported no bowel control.

17 Sixteen of 677 with defunctioning stoma (2.2%) developed clinical leak; 24 of 450 without

18 ence interval 0.20-0.65) and fewer permanent stomas (23.4% vs 42.4%, P < 0.001).

19 re were no significant changes for permanent stoma (25.4% to 25.3% in the high-intensity group and 20

20 2 vs 50.4% LC, p = 0.68), although permanent stoma (38.0% vs 29.8%, P = 0.13) and anastomotic breakdo

21 total of 286 procedures (132 with associated stoma, 46%) were performed including 217 conservative (7

22 ) developed clinical leak; 24 of 450 without stoma (6.3%) developed leak (P = 0.005).

23 After reversal of the stoma a condition known as low anterior resection syndro

24 antly increased risks of permanent diverting stomas across different tumor heights, particularly in u

25 tudy evaluates bacterial colonization of the stoma after transcutaneous osseointegrated prosthetic sy

26 Chronic pain, stomas, altered bowel function and mobility issues impac

27 ry implant passed transcutaneously through a stoma and connected to an external prosthetic limb.

28 ces were found in only 2 measures (permanent stoma and in-hospital mortality), but these differences

29 ent of RVF, including early use of temporary stoma and major procedure in case of failure of previous

30 interacts with future avoidance of permanent stoma and quality of life (QoL) is studied.

31 ce to solid stool for patients with baseline stomas and for patients undergoing total anal reconstruc

32 ndications, complications, and management of stomas and identifies the factors that are associated wi

33 the patients had closure of their diverting stomas and maintained healed rectourethral fistulas.

34 d peritonitis, coagulopathy, age, the use of stoma, and chronic kidney disease as strong predictors o

35 e, surgical site, postoperative comorbidity, stoma, and nasogastric tube) with LRD patients having an

36 ance of tumor from anal verge, defunctioning stoma, and pathologic stage, clinical leak was not assoc

37 eveloping soybean embryos do not form mature stoma, and stomatal differentiation is arrested at the g

38 th active or recurrent disease, those with a stoma, and those at the extremes of the age range (< 55

39 group 2, >/=50% colon-in-continuity without stoma; and group 3, other colon anatomies), and disease

40 Intestinal transplantation without stoma appears to be an acceptable practice model without

41 The two guard cells of a stoma are produced by a single symmetric division just b

42 he formation and complications of intestinal stomas are the following; colostomy formation should rar

43 section with anastomosis and a defunctioning stoma as primary surgery, >6 months since stoma reversal

44 ysis was planned for patients who received a stoma at the time of initial operation.

45 ting pathogen entry into leaves, leading to 'stoma-based immunity' as the first line of defense.

46 However, the variation in stoma-based innate immunity across the diversity of vasc

47 how individuals experience living with a new stoma but little is known of the individual experience o

48 Intestinal stomas can pose significant challenges for long-term (>

49 nence and one patient had not had a covering stoma closed.

50 al stay (12.2 vs 12.2; P = 0.99) and rate of stoma closure (80.1% vs 77.3%; P = 0.53) between groups.

51 Conventional stoma closure (n = 40) vs stoma closure with preventive

52 ients were randomized to either conventional stoma closure (n = 44) or synthetic mesh-reinforced stom

53 losure (n = 44) or synthetic mesh-reinforced stoma closure (n = 44).

54 associated with the complications related to stoma closure (p < 0.001).

55 tly higher percentage of formed stools after stoma closure (P=0.001).

56 ration, length of hospital stay, and rate of stoma closure at 6 months.

57 my for rejection) and accepted or quiescent (stoma closure in stable transplant recipients) grafts we

58 the time of any operative resection, such as stoma closure or revision.

59 nts including hospital stay, blood loss, and stoma closure rates.

60 , previous mesh placement within 3 cm of the stoma closure site, allergy or contraindication for mesh

61 Mean time from surgery to stoma closure was 6 +/- 4 months.

62 ing of the operating surgeon and the type of stoma closure were significantly associated with the com

63 Conventional stoma closure (n = 40) vs stoma closure with preventive synthetic mesh placement i

64 leakage of the small bowel anastomosis after stoma closure.

65 One patient declined stoma closure.

66 6%) was the most frequent complication after stoma closure.

67 exner Fecal Incontinence Questionnaire after stoma closure.

68 truction may reduce morbidity and need for a stoma compared with ES, concern has been raised, about l

69 ith early closure (8-13 days) of a temporary stoma compared with standard procedure (closure after >

70 tcomes of intestinal transplantation without stoma, compared to conventional transplant with stoma.

71 Most patients have to live with their stoma complicated by a parastomal bulge.

72 ioperative transfusion (OR: 1.6, P < 0.010), stoma constructed (OR: 1.4, P < 0.001), and operation la

73 At 4.5 years, 7/11 patients had avoided stoma construction.

74 ory bowel disease, as indication for initial stoma construction.

75 orectal cancer and who underwent stenting or stoma creation from October 1, 2009, through December 31

76 observations led us to question the need for stoma creation in intestinal transplantation.

77 ompare outcomes after palliative stenting vs stoma creation in patients with MLBO requiring emergency

78 did not affect the laparoscopic approach or stoma creation rate among curative patients.

79 Early closure (8-13 days after stoma creation) of a temporary ileostomy was compared wi

80 orrelated with the requirement for permanent stoma creation, while only free anastomotic leak was ass

81 Palliative stenting vs stoma creation.

82 Patients in the Danish Stoma Database completed the Short-form 36 health survey

83 it often causes discomfort and leakage from stoma dressing.

84 ion-based study was to compare decompressing stoma (DS) as bridge to surgery (BTS) with emergency res

85 Exclusion criteria included postoperative stoma, emergent or urgent operation, and diagnosis of in

86 potential to reduce the need for a permanent stoma even further than is currently the case.

87 Patients with a stoma, fistula, or soft-tissue infection were excluded.

88 an independent risk factor for recurrence or stoma formation and no reduction in QoL scores to sugges

89 .0%) was the most common anatomical site for stoma formation followed by the ileum (18, 10.8%).

90 independent risk factors for recurrence and stoma formation identified.

91 Symptoms recurred leading to permanent stoma formation in 1 patient, whereas one other develope

92 or expression1/scream2 that are required for stoma formation in Arabidopsis.

93 as the most common indication for intestinal stoma formation in children, while bowel perforation (14

94 y been treated with open colon resection and stoma formation with risk for reoperations, morbidity, a

95 aracteristics, operative details, morbidity, stoma formation, recurrence requiring surgery and QoL da

96 epair, with selective defunctioning proximal stoma formation.

97 conventionally been managed by resection and stoma formation.

98 c lavage, resulting in reduced mortality and stoma formation.

99 PSH is the most frequent complication after stoma formation.

100 f healthcare experiences of people following stoma-forming surgery were identified: Relationships wit

101 others providing care for patients following stoma-forming surgery.

102 recurrence free survival (P = 0.032) but not stoma free survival P = 0.62 on univariate analysis.

103 Recurrence and stoma free survival was calculated for each group and in

104 12-month stoma-free survival was significantly better for patient

105 The primary endpoint was 12-month stoma-free survival.

106 ed by regaining physical capacity, mastering stoma function, purposeful care, and acceptance and supp

107 ortality, secondary operations, recurrences, stomas, functional outcomes, and quality of life.

108 ing an operation, particularly the fear of a stoma, generated anxiety and concern for many of these y

109 nts (mean [SD] age, 69.9 [14.4] years in the stoma group and 70.9 [16.8] years in the stent group; 87

110 4 non-Hispanic white patients [65.9%] in the stoma group and 90 [52.3%] in the stent group).

111 rs in the stent group; 87 men [50.3%] in the stoma group and 90 [52.3%] in the stent group; and 114 n

112 oscopic and open resections with a diverting stoma had a higher incidence of AL than those without a

113 d with surgery including colon resection and stoma (Hartmann procedure) with considerable postoperati

114 Careful patient selection for defunctioning stoma helps reduce risk of clinically significant anasto

115 lavage was compared with colon resection and stoma in a randomized controlled multicenter trial, DILA

116 reticulate patterning of veins and dispersed stoma in eudicots.

117 s paralogs are required for the formation of stoma in leaves and stomatal precursor complexes in matu

118 The vaginal vault was exteriorized as a stoma in the lower right abdominal wall.

119 y 102,000 individuals live with an excretory stoma in the UK.

120 RF reaching a 50-mum depth of chick corneal stoma increased dramatically after exposure to NC-1059 f

121 Relocation of the stoma may be associated with a new ulceration and should

122 Primary anastomosis with defunctioning stoma may be the optimal strategy for selected patients

123 can Society of Anesthesiologists) grade, and stoma moderated the impact of complications in the short

124 actors considered were the risk of permanent stoma, morbidity, and mortality from the primary or reve

125 uded the presence of infected mesh (n = 45), stoma (n = 24), concomitant gastrointestinal (GI) surger

126 g anesthesia (n=1), and complications of the stoma (n=2).

127 fts in 16 patients and "Study group (without stoma)," n = 16 grafts in 15 patients.

128 renal function between "Control group (with stoma)," n = 18 grafts in 16 patients and "Study group (

129 Data (age, gender, stage, defunctioning stoma, neoadjuvant treatment, distance from anal verge,

130 ll resectable LARC, with excessive diverting stoma nonreversal as the trade-off.

131 t in multivariable models only for permanent stoma (odds ratio [OR], 1.67; 95% CI, 1.24-2.24; P < .00

132 als, with a maximum of 3.7% recovered at the stoma of one individual.

133 reathing by the patient through the tracheal stoma, one would expect low levels of muscle activation

134 al advancement flap (n = 46; 16%), diverting stoma only (n = 27; 9%), plug (n = 15; 5%), glue (n = 13

135 hat highly Tl-enriched crystals occur in the stoma openings of the leaves.

136 ng the transplant recipients, 17 (85%) had a stoma or enterocutaneous fistula, and the mean (SD) resi

137 results when divisions next to a preexisting stoma or precursor are oriented so that the new meristem

138 morbidity index (OR 1.4 per point), and loop stoma (OR 2.2); longer length of stay (OR 0.5) and age 6

139 pared with being in remission), and having a stoma (OR, 2.10; 95% CI, 1.86 to 2.36 compared with no s

140 (OR): 6.4 (2.9-14.2); P < 0.001], diverting stoma [OR: 3.5 (1.4-8.7); P = 0.009], less than 9 months

141 condary outcome was intraoperative diverting stoma outcomes.

142 65 (19.8%), respectively, received permanent stoma (P < .001).

143 , 126 primary anastomoses with defunctioning stoma (PADS), and 6619 Hartmann's procedures (HP) were c

144 uding degree of contamination, presence of a stoma, participant body mass index, and skin preparation

145 The intestinal stomas performed at BMC are associated with various comp

146 uid and electrolyte disorders, male sex, and stoma placement independently increased the risk of leak

147 Stoma placement should be performed to best facilitate c

148 uid and electrolyte disorders, male sex, and stoma placement were associated with a higher risk of AL

149 Obesity, bridged repair, and concurrent stoma presence/creation were independent predictors of H

150 This must be weighed against the lower stoma prevalence in this group.

151 The stoma prevalence was 8% (n = 4) in the laparoscopic lava

152 Stoma prolapse (18, 41.9%) was the most frequent complic

153 A stoma provided a safe alternative but was only effective

154 eted the Short-form 36 health survey and the stoma-QOL questionnaire.

155 es of minimally invasive surgery and the low stoma rate make the bridge-to-surgery approach highly va

156 s were 3-year overall survival and permanent stoma rate.

157 I, 0.59-0.92) but higher permanent diverting stoma rates (20.6% vs 11.1%; relative risk [RR], 1.91; 9

158 There were clinical trends in permanent stoma rates and anastomotic leaks in favor of LC but wit

159 Unit admissions, 30 and 90-day mortality, or stoma rates at 12 months.

160 The stoma-regulated LRU response to CO(2) suggests that COS

161 th treatments was low [surgery (inclusive of stoma related to the elective colectomy), 4.0%; medical

162 iming of surgery were the main predictors of stoma-related complications (p < 0.034 and 0.013), where

163 Stomas remained permanent in 27% of HP and in 8% of PADS

164 Reversal of a stoma resulted in fewer severe bowel problems but more m

165 associated with longer time from surgery to stoma reversal (6.8 vs. 4.8 months; p = 0.03) and with a

166 Surgical site infection following stoma reversal (SR) poses a substantial burden to the pa

167 The likelihood of stoma reversal after primary anastomosis has been report

168 Prolonged time until stoma reversal and adjuvant chemotherapy emerged as the

169 Stoma reversal is associated with few complications.

170 tanding of surgical site infection following stoma reversal may help us identify methods to decrease

171 diverting ileostomy, n = 32), with a planned stoma reversal operation after 3 months in both groups.

172 all complication rate for both resection and stoma reversal operations was comparable (80% vs 84%, P

173 % and morbidity 67% vs 75% in HP vs PA), the stoma reversal rate after PA with diverting ileostomy wa

174 , its impact on sphincter function following stoma reversal remains unclear.

175 as, the placement of a synthetic mesh during stoma reversal should be considered.

176 ional outcomes were assessed six months post-stoma reversal using the Low Anterior Resection Syndrome

177 Patients who underwent elective stoma reversal were included.

178 ng stoma as primary surgery, >6 months since stoma reversal, anastomosis without signs of leakage or

179 ng term follow up study (median 4 years from stoma reversal, range 1-8).

180 d alive, and secondary operations, including stoma reversal, were performed in 36% (n = 26) vs 35% (n

181 astomotic complications (reoperation, rescue stoma, revision of an anastomosis, and percutaneous drai

182 [Li, C., Stoma, S., Lotta, L.A., Warner, S., Albrecht, E., Allion

183 C, extraintestinal manifestations, permanent stoma, short bowel syndrome), and long-term complication

184 ious complications, comorbidity burden, loop stoma, shorter length of stay, and age.

185 ive options using a catheterizable abdominal stoma should be discussed with patients with intractable

186 The primary outcome measure was radiological stoma site incisional hernia after 12 months.

187 The rate of stoma site incisional hernia was 17.9% (n = 7) in the co

188 To prevent stoma site incisional hernias, the placement of a synthe

189 ic mesh in the retromuscular space prevented stoma site incisional hernias.

190 intestinal system, TRPM5 is expressed in the stoma, small intestine, and colon.

191 >10 cm impaired HRQoL (P < 0.01) across all stoma specific and generic domains.

192 icantly impaired (P < 0.01) HRQoL across all stoma specific and generic health domains compared to pa

193 .4 (interquartile range 3.1-6.0) years after stoma surgery.

194 ed in the stroma surrounding CCH compared to stoma surrounding normal terminal duct lobular units (TD

195 Among patients receiving a stoma, there was also no difference in SSI between the e

196 When stratified for defunctioning stoma, there was no association between clinical leak an

197 An intestinal stoma, though a life-saving procedure on the care of man

198 and digesta are diverted from the body via a stoma to a colostomy bag).

199 of care that assists individuals with a new stoma to adapt to and accept a changed sense of embodied

200 Many have a defunctioning stoma to reduce risk of clinically significant leakage.

201 ness plications within the gastric pouch and stoma using the StomaphyX device with SerosFuse fastener

202 e control, hollow visceral injury (HVI), and stoma utilization.

203 l stenosis, the OR associated with permanent stoma was 33 (P = 0.0023).

204 Defunctioning stoma was associated with lower incidence of clinical le

205 er a median delay of 2.2 months (0.8-121.6), stoma was closed in 56 patients.

206 patients assigned to primary anastomosis, no stoma was constructed.

207 * Consequently, optimal function per stoma was dependent on maintaining one epidermal cell sp

208 Consequently, optimal function per stoma was dependent on maintaining one epidermal cell sp

209 The stoma was not closed in 4 of 456 (0.6%) patients.

210 Both patients whose stoma was relocated developed an ulcer at the new site.

211 -sectional study of patients with intestinal stomas was conducted at Bugando Medical Centre (BMC) bet

212 p to 3 months after closure of the diverting stoma were graded according to the Dindo classification.

213 olon cancer with primary anastomosis without stoma, were included in a prospective online database (S

214 .9%) was the most frequent complication of a stoma, whereas, surgical site infection (9, 34.6%) was t